Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary.
The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro diagnostics market.
Read the whole story at our sister site, Drug Delivery Business
The post Abbott’s $5B acquisition of Alere set to close tomorrow appeared first on MassDevice.
from MassDevice http://ift.tt/2fDZ5Dy
Cap comentari:
Publica un comentari a l'entrada